continue to manipulate this stock….now 2
of the GREATEST pRS ever…. Contract with
regeneron and now moderna where each
company GAVE 30 million each to this tiny
under 5.00 company….. this should go way
up even from opening levels of 2.90
Good luck to all
Recent CTMX News
- CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:30:38 PM
- CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/11/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:02:08 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:00:31 PM
- U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher • IH Market News • 03/11/2024 10:39:47 AM
- CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024 • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- CytomX Therapeutics to Present at Upcoming March Investor Conferences • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b • GlobeNewswire Inc. • 01/24/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:44:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:41:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:40:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:38:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:37:27 AM
- CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference • GlobeNewswire Inc. • 01/12/2024 01:00:00 PM
- CytomX Therapeutics Outlines 2024 Company Priorities and Milestones • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:14:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:12:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:10:48 PM
- CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/21/2023 01:00:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM